USP8 and ovarian cancer: Indeed, knockdown of USP8 in ovarian cancer cells produces a downregulation of the anti-apoptotic action of FLIPL associated with enhanced susceptibility to cisplatin-induced apoptosis resulting from enhanced caspase 3/7 activation 90.